TSX News -
Trillium Therapeutics to Present at Investor and Scientific Conferences in the First Quarter
TORONTO, ONTARIO–(Marketwired – Feb. 9, 2018) – Trillium Therapeutics Inc. (NASDAQ:TRIL)(TSX:TRIL), a clinical stage immuno-oncology company developing innovative therapies for [...]